Click here to view this email on your mobile device
View this email in your Web browser: http://whatcounts.jobson.com/dm?id=%%SUBSCRIBER_ID_TAG%%
July 30, 2015
VMail Technology
www.visionmonday.com   Facebook Twitter
In This Edition

Eye²

Six15’s New Smart Glasses and Platform

WEB TECH

Optovue Debuts Online Learning Portal
Vycor Introduces NovaVision

Eye²

Six15 Technologies Intros Sleek Smart Glasses and Integrated Software


More Images
Product: Infinity Platform
Top Line: Six15 Technologies is launching a smart glasses and turnkey software and integration solution. The smart glasses and platform is called Infinity Platform and is currently being used by select developers and strategic partners. It will be available worldwide for non-consumer applications in the first quarter of 2016.
Close Up: The smart glasses have been designed around the more demanding requirements of the commercial markets to while delivering a sleek, light and refined design; the Infinity.1’s display uses a patented miniaturized LCD-based system with a 17.5 degree field of view. Infinity.1 can be tailored to the specific application with fully integrated modules for video, audio, and communication upgrades.
Vital Stats: Safe, durable, and easy to clean lenses make these ideal for all environments. Polarized lenses will be available for higher light or outdoor environments.
www.six-15.com

Top Send your comments to VM

WEB TECH

Optovue Launches Optovue Academy, an Online Learning Portal


Product: Optovue Academy
Top Line: Ophthalmic device maker Optovue is launching Optovue Academy, an online learning portal offering clinical education, technician training and practice development tracks.
Close Up: Content will be delivered via video PowerPoint presentations, recordings of live presentations, a library of research documents, a forum where learners can comment, and a calendar of live events supported or hosted by Optovue Academy.
“Optovue Academy was created to give eyecare professionals the clinical knowledge they need to offer a higher level of medical eye care with OCT,” said Larry Alexander, OD, FAAO, senior director of clinical education for Optovue. “In addition, this program supports the practice as a whole by providing training for technicians and resources for growing the practice with advanced imaging technology.” Marketing director Christina Kirby added, “Optovue is committed to our customers’ success with OCT.” “This program demonstrates that commitment by giving eye care professionals the tools they need to enhance patient care with their Optovue OCT, improve operator scan acquisition skills and maximize the return on their investment in the instrumentation.”
Vital Stats: Optovue Academy will be updated continually with new video courses, articles and discussion threads. To learn more or request login credentials, visit www.OptovueAcademy.com.
www.optovue.com; (866) 344-8948

Top Send your comments to VM

Vycor Announces Commercial Release of Its NovaVision Web-Deliverable Therapy Suite


Product: NovaVision Web-Deliverable Therapy Suite
Top Line: Vycor Medical is releasing its Internet-delivered therapy suite in the U.S. This therapy suite, consisting of its lead Vision Restoration Therapy (VRT) and its NeuroEyeCoach eye-movement compensation therapy, is delivered directly to patients over the Internet onto their own computers replacing the company's current “prototype hardware centric” model. NovaVision has been working to take its VRT therapy prototype and develop it into an affordable, scalable therapy offering that offers broader patient benefits. VRT will going forward be provided alongside NovaVision's NeuroEyeCoach compensatory therapy in one Internet delivered therapy suite.
Close Up: Two things happen when someone suffers from vision related disorders following a stroke or brain injury: there is a loss of visual field as well as difficulty with eye movement, affecting the ability to integrate visual information. VRT addresses the restoration of lost vision while NeuroEyeCoach addresses patients' difficulty with their eye movements and their ability to integrate visual information, allowing them to make the most of their remaining vision, The two therapies provided in a suite are therefore highly complementary and ensure broad benefits to NovaVision's patients.
NovaVision is now positioned, for the first time, with the suite of therapies and product offerings to deliver on its strategic vision: to provide a clinically supported, affordable and scalable visual therapy solution offering broad benefits to those suffering visual impairment following neurological damage; and to offer solutions for both patients and physicians alike.
For patients:
VRT and NeuroEyeCoach Therapy Suite. NovaVision offers these two complementary therapies, internet-delivered in a package for $900.
NeuroEyeCoach. For patients with visual impairments who are not suitable, for whatever reason, for VRT, NovaVision provides NeuroEyeCoach on its own for $450.
For physicians:
Vision Diagnostic (VIDIT). The diagnostic component of VRT that enables therapists to perform high-resolution visual field tests in less than 10 minutes to screen for visual field deficits.
NeuroEyeCoach Pro Center. Enables stroke rehabilitation and other centers to treat patients while in their care, both as in-patient and out-patient.
NovaVision and NeuroEyeCoach Pro Physician. Enables physicians to register patients in their clinic who complete the therapy at home, supported by NovaVision but monitored by the physician through a dedicated portal.
Vital Stats: VRT is a prescription product and the only FDA-cleared therapy (510k) for the restoration of vision loss from neurological damage. VRT is supported by 15 years of clinical research and over 20 studies including a 302 patient study in which notable improvements were seen in 70 percent of the patients. NeuroEyeCoach is also clinically supported being based on research that has been the subject of 14 clinical studies on a total of 591 patients and has FDA registration.
For an overview of NovaVision see NovaVision Video.
www.vycormedical.com, www.vycorvbas.com, www.novavision.com; (561) 558-2020

Top Send your comments to VM

BACK TO TOP

Send Us Your News & Ideas

Andrew Karp, Group Editor, Lenses and Technology

Send us news about developments in dispensing technology, lens processing equipment, software, diagnostic and web technology. Or provide us with subjects for future stories or topics you'd like to see covered. Contact VMail Technology’s Editor Andrew Karp at akarp@jobson.com.


VMail Technology is a service of Jobson Medical Information LLC, the publisher of VisionMonday®,
440 Ninth Ave, 14th Floor, New York NY 10001.

If you do not wish to receive future VMail Technology e-mails, please click UNSUBSCRIBE.

© 2018 Jobson Medical Information LLC All Rights Reserved EyesWay content is developed, sourced and
reported by the editors of EyesWay, the international news portal. VMail provides that content to its
subscribers as part of an exclusive news exchange agreement.